Procedures | Screening visit | Daya 1 | Day 8 ± 1 | Day 15 ± 2 | Day 22 ± 2 | Day 29 ± 2 | End of treatment |
---|---|---|---|---|---|---|---|
Informed consent form | X | ||||||
Inclusion/exclusion criteria | X | ||||||
Randomization | X | ||||||
Demographic data | X | ||||||
Medical history | X | ||||||
Size | X | ||||||
Weight | X | X | X | X | X | X | X |
Physical examination: vital signs | X | X | X | X | X | X | X |
ECOG | X | X | |||||
Electrocardiogram | X | X | X | X | X | X | X |
Study treatment | x | x | x | x | x | ||
Hemogram | X | X | X | X | X | X | X |
Biochemistry | X | X | X | X | X | X | X |
Coagulation | X | X | X | X | X | X | X |
Pregnancy test | X | ||||||
Concomitant medication/antimicrobials | X | X | X | X | X | X | X |
Adverse effects | X | X | X | X | X | X | |
Microbiological culture | X | X | X | X | X | X | X |
Stool sample for microbiome analysis | X | Xb |